Muneer A. Satter's most recent trade in Annexon Inc was a trade of 44,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Annexon Inc | Muneer A. Satter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
Annexon Inc | Satter A. Muneer | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 26 Dec 2023 | 350,000 | 7,406,024 | - | 2.9 | 1,008,000 | Common Stock |
Annexon Inc | Muneer A. Satter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Annexon Inc | Muneer A. Satter | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.80 per share. | 10 Feb 2023 | 2,647,058 | 7,056,024 | - | 6.8 | 17,999,994 | Common Stock |
Annexon Inc | Muneer A. Satter | Director | Purchase of securities on an exchange or from another person at price $ 3.84 per share. | 07 Jul 2022 | 2,453,988 | 4,408,966 | - | 3.8 | 9,423,314 | Common Stock |
Annexon Inc | Muneer A. Satter | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jul 2022 | 613,497 | 613,497 | - | - | Warrants (Right to Buy) | |
Annexon Inc | Muneer A. Satter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Annexon Inc | Muneer A. Satter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Rein Therapeutics Inc. | Muneer A. Satter | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 08 Jan 2021 | 9,000,000 | 16,609,449 (59%) | 32% | 1.1 | 9,900,000 | Common Stock |
Annexon Inc | Muneer A. Satter | None | 28 Jul 2020 | 5,537,036 | 0 | - | - | Series C Preferred Stock | ||
Annexon Inc | Muneer A. Satter | None | 28 Jul 2020 | 4,016,573 | 0 | - | - | Series B Preferred Stock | ||
Annexon Inc | Muneer A. Satter | None | 28 Jul 2020 | 3,095,238 | 0 | - | - | Series A-1 Preferred Stock | ||
Annexon Inc | Muneer A. Satter | None | 28 Jul 2020 | 2,812,543 | 0 | - | - | Series D Preferred Stock | ||
Annexon Inc | Muneer A. Satter | None | 28 Jul 2020 | 1,754,978 | 1,754,978 | - | - | Common Stock | ||
Annexon Inc | Muneer A. Satter | None | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 28 Jul 2020 | 200,000 | 1,954,978 | - | 17 | 3,400,000 | Common Stock |
Rein Therapeutics Inc. | Muneer A. Satter | Other, See Remarks | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 08 Jun 2020 | 3,700,000 | 7,609,449 (27%) | 13% | 1.1 | 4,070,000 | Common Stock |